4.8 Article

Angiotensin-II Type 1 Receptor-Mediated Janus Kinase 2 Activation Induces Liver Fibrosis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

The endocannabinoid N-arachidonoyl dopamine (NADA) selectively induces oxidative stress-mediated cell death in hepatic stellate cells but not in hepatocytes

Alexandra Wojtalla et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)

Article Biochemistry & Molecular Biology

Angiotensin signalling in pulmonary fibrosis

Bruce D. Uhal et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)

Article Biochemistry & Molecular Biology

Hepatocyte-specific Deletion of Janus Kinase 2 (JAK2) Protects against Diet-induced Steatohepatitis and Glucose Intolerance

Sally Yu Shi et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2012)

Article Gastroenterology & Hepatology

HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects

Sabine Klein et al.

JOURNAL OF HEPATOLOGY (2012)

Review Pharmacology & Pharmacy

JAK2 the future: therapeutic strategies for JAK-dependent malignancies

Lindsay M. LaFave et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2012)

Article Medicine, Research & Experimental

Abrogation of growth hormone secretion rescues fatty liver in mice with hepatocyte-specific deletion of JAK2

Brandon C. Sos et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Article Medicine, Research & Experimental

Hepatitis C virus core protein induces fibrogenic actions of hepatic stellate cells via toll-like receptor 2

Martin Coenen et al.

LABORATORY INVESTIGATION (2011)

Article Biochemistry & Molecular Biology

IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma

Fang-Ming Gu et al.

MOLECULAR CANCER (2011)

Review Pharmacology & Pharmacy

Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status

Terry K. W. Ma et al.

BRITISH JOURNAL OF PHARMACOLOGY (2010)

Article Biochemistry & Molecular Biology

Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation

Volker Rudolph et al.

NATURE MEDICINE (2010)

Article Biochemistry & Molecular Biology

The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure

Christophe Guilluy et al.

NATURE MEDICINE (2010)

Article Medicine, General & Internal

Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis.

Srdan Verstovsek et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Gastroenterology & Hepatology

Daily genetic profiling indicates JAK/STAT signaling promotes early hepatic stellate cell transdifferentiation

Ashley M. Lakner et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2010)

Article Gastroenterology & Hepatology

Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver

Montserrat Moreno et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)

Article Gastroenterology & Hepatology

A novel model of CCl4-induced cirrhosis with ascites in the mouse

Marco Domenicali et al.

JOURNAL OF HEPATOLOGY (2009)

Review Biochemistry & Molecular Biology

Novel aspects of the renin-angiotensin-aldosterone-system

Gunter Wolf

FRONTIERS IN BIOSCIENCE-LANDMARK (2008)

Review Gastroenterology & Hepatology

Mechanisms of hepatic fibrogenesis

Scott L. Friedman

GASTROENTEROLOGY (2008)

Review Gastroenterology & Hepatology

Mechanisms of extrahepatic vasodilation in portal hypertension

M. Hennenberg et al.

Review Biochemistry & Molecular Biology

Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario

Maurizio Parola et al.

MOLECULAR ASPECTS OF MEDICINE (2008)

Review Cell Biology

Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system

Puja K. Mehta et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)

Article Medicine, General & Internal

A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited

W Laleman et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2006)

Article Gastroenterology & Hepatology

Effects of six months losartan administration on liver fibrosis in chronic hepatitis C patients: A pilot study

Silvia Sookoian et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2005)

Article Gastroenterology & Hepatology

Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice

L Yang et al.

JOURNAL OF HEPATOLOGY (2005)

Article Gastroenterology & Hepatology

Vascular, hemodynamic and renal effects of low-dose losartan in rats with secondary biliary cirrhosis

J Heller et al.

LIVER INTERNATIONAL (2005)

Article Gastroenterology & Hepatology

Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats

R Bataller et al.

HEPATOLOGY (2005)

Article Medicine, General & Internal

Acute haemodynamic effects of losartan in anaesthetized cirrhotic rats

J Heller et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2003)

Article Gastroenterology & Hepatology

Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension

V Croquet et al.

JOURNAL OF HEPATOLOGY (2002)

Article Gastroenterology & Hepatology

Angiotensin II induces contraction and proliferation of human hepatic stellate cells

R Bataller et al.

GASTROENTEROLOGY (2000)

Review Gastroenterology & Hepatology

Complications of cirrhosis. I. Portal hypertension

J Bosch et al.

JOURNAL OF HEPATOLOGY (2000)